Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics Partners with Colombian Lab on Genetic Testing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pathway Genomics has partnered with the Instituto de Referencia Andino (IRA), a clinical lab division of Rochem Biocare, to offer Pathway's personal genetic health and ancestry testing to residents of Latin America.

IRA is a high-complexity lab based in Bogota, Colombia, with 200 affiliate labs in Colombia, Ecuador, and Peru.

In addition to offering Pathway's tests, the firms will collaborate on identifying genetic markers linked to common health conditions in Latin and Hispanic populations. The markers will then be used by Pathway to further tailor its custom-designed DNA genotyping technology, enabling it to offer genetic testing to the broader Latin American populations, it said.

"By providing access to residents of Latin America we can expand our services into new communities, helping more people learn about the benefits of personal genetic testing," Jim Woodman, VP of business development for San Diego-based Pathway, said in a statement.

Financial and other terms of the alliance were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.